In “Timing of Colposcopy After Cervical Cytologic Abnormalities” by T.-M. Kuo, V.B. Bernard, N.D. Berkman, C.K. Martin, and L.C. Richardson (Obstet Gynecol 2010;115:629–36), the Level of Evidence at the end of the abstract is incorrect. The correct Level of Evidence is “II.” The editorial office regrets this error.
There were errors in Figure 1 in the article “Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial” by M. McClung, P. Miller, C. Recknor, P. Messenbrink, C. Bucci-Rechtweg, and C.-L. Benhamou (Obstet Gynecol 2009;114:999–1007). The figure should have shown that zoledronic acid or placebo was received at baseline and 12 months, not baseline and 24 months. The corrected figure is printed below. The corresponding author regrets these errors.© 2010 by The American College of Obstetricians and Gynecologists.